Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

103
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
103
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

99
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
99
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

185
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
185
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

156
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
156
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Different Methods for the Meta-Analysis of Diagnostic Test Accuracy Studies-A Simulation Study.

Biometrical journal. Biometrische Zeitschrift·2026
Same author

Glucagon-Like Peptide-1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Diabetes, obesity & metabolism·2026
Same author

Low Skeletal Muscle Mass Predicts 30-day Mortality in Patients With Acute Pulmonary Embolism. A Multicenter Study.

Academic radiology·2026
Same author

Ascertainment of Cancer Cases in the German National Cohort (NAKO): Methods and Initial Results.

Deutsches Arzteblatt international·2026
Same author

Photon counting computed tomography in head and neck squamous cell carcinoma: iodine concentration and histopathological features.

Journal of cancer research and clinical oncology·2026
Same author

Integration of cBioPortal into Medical Education: Evaluating Its Didactic Potential in the Context of Personalized Medicine.

Studies in health technology and informatics·2026
Same journal

Predictor-Assisted Nonparametric Graphical Models With Multivariate Error-Prone Data.

Statistics in medicine·2026
Same journal

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Statistics in medicine·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

Measurement of Lifespan in Drosophila melanogaster
10:00

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

34.2K

Modeling Chronic Disease Mortality by Methods From Accelerated Life Testing.

Marina Zamsheva1,2, Alexander Kluttig1,2, Andreas Wienke1,2

  • 1Institute of Medical Epidemiology, Biostatistics, and Informatics, Medical Faculty of the Martin-Luther-University Halle-Wittenberg, Halle, Saale, Germany.

Statistics in Medicine
|October 9, 2024
PubMed
Summary
This summary is machine-generated.

We developed a new statistical model to analyze chronic disease mortality in cohort studies, specifically for Type 2 diabetes. This model accounts for disease onset, semi-competing risks, and late entry, improving mortality prediction.

Keywords:
Gompertz distributionType 2 diabeteslifetime analysismaximum likelihoodtampered random variable

More Related Videos

Author Spotlight: Automated Lifespan Monitoring – Discovering Aging Dynamics with the Lifespan Machine
08:53

Author Spotlight: Automated Lifespan Monitoring – Discovering Aging Dynamics with the Lifespan Machine

Published on: January 26, 2024

979
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Related Experiment Videos

Last Updated: Jun 11, 2025

Measurement of Lifespan in Drosophila melanogaster
10:00

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

34.2K
Author Spotlight: Automated Lifespan Monitoring – Discovering Aging Dynamics with the Lifespan Machine
08:53

Author Spotlight: Automated Lifespan Monitoring – Discovering Aging Dynamics with the Lifespan Machine

Published on: January 26, 2024

979
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Reliability Theory

Background:

  • Chronic diseases pose significant public health challenges, necessitating accurate mortality prediction from cohort data.
  • Existing models may not fully capture the complexities of chronic disease progression, including semi-competing risks and cohort entry variations.

Purpose of the Study:

  • To propose and illustrate a novel parametric model for chronic disease mortality analysis using cohort data.
  • To address semi-competing risks (disease diagnosis and death) and cohort structure (late entry, prevalent/incident cases).

Main Methods:

  • Utilized concepts from accelerated life testing in reliability theory.
  • Developed a parametric model conceptualizing chronic disease as an enhanced stressor shortening lifetime.
  • Incorporated methods for semi-competing risks and late cohort entry.
  • Extended the model for interval-observed age at diagnosis.
  • Employed Maximum Likelihood estimation with a Gompertz distribution assumption.

Main Results:

  • The proposed parametric model effectively describes chronic disease mortality from cohort data.
  • A simulation study demonstrated the successful estimation of model parameters.
  • The model was illustrated using data from the Cardiovascular Disease, Living and Ageing in Halle (CARLA) study.

Conclusions:

  • The developed parametric model offers a robust framework for analyzing chronic disease mortality in cohort studies.
  • The model's ability to handle semi-competing risks and cohort complexities enhances its applicability.
  • This approach provides improved insights into mortality patterns for diseases like Type 2 diabetes.